Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 204
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02057172 | Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes | ||
| NCT04324918 | Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis | ||
| NCT01806818 | Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients | ||
| NCT01828359 | The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy. | ||
| NCT03374241 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide) | ||
| NCT04510415 | Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT02552667 | Efficacy and Safety of HCP1102 Capsule | ||
| NCT05481307 | A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203 | ||
| NCT01455571 | Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors | ||
| NCT02294539 | Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients | ||
| NCT05949333 | Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy | ||
| NCT01724814 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A | ||
| NCT04775706 | Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects | ||
| NCT05024721 | Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis | ||
| NCT04975711 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers | ||
| NCT06234397 | Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors | ||
| NCT03228277 | Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA | ||
| NCT05155995 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT02941679 | Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients | ||
| NCT03882112 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects | ||
| NCT04204629 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects | ||
| NCT05199129 | Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients | ||
| NCT01548157 | Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule | ||
| NCT02243319 | Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 | ||
| NCT00979563 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies | ||
| NCT02554136 | Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816 | ||
| NCT02473900 | Evaluating the Bioequivalence of HIP1403, HGP0919 | ||
| NCT03284502 | HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT02715401 | PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers | ||
| NCT03372850 | Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations | ||
| NCT01505777 | Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea | ||
| NCT07297693 | A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers | ||
| NCT04732416 | HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) | ||
| NCT04788290 | An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol | ||
| NCT01491503 | A Drug Interaction Study of Montelukast and Levocetirizine | ||
| NCT01822340 | Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients | ||
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | ||
| NCT07527650 | Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus | ||
| NCT03897868 | A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension | ||
| NCT01127217 | Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension | ||
| NCT04346862 | Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT02587988 | Trial to Evaluate the Efficacy and Safety of HCP1302 | ||
| NCT04946903 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 | ||
| NCT05548543 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT02485652 | Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung | ||
| NCT02940314 | Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers | ||
| NCT01718847 | NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors | ||
| NCT03479073 | Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation |
